收藏切换
Research progress on drug and new intervention strategies for epilepsy based on gut microbiota regulation
收藏切换
Ru FENG1, Heng-tong ZUO1, Jin-yue LU1, Bo ZHANG2, Jian-dong JIANG1, Yan WANG1, *, Qing LIU3, *
Acta Pharmaceutica Sinica | 2026, 61(1) : 84 - 93
Less
收藏切换
Acta Pharmaceutica Sinica | 2026, 61(1): 84-93
• Reviews •
Research progress on drug and new intervention strategies for epilepsy based on gut microbiota regulation
Full
Ru FENG1, Heng-tong ZUO1, Jin-yue LU1, Bo ZHANG2, Jian-dong JIANG1, Yan WANG1, *, Qing LIU3, *
Affiliations
  • 1Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • 2Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100005, China
  • 3Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100005, China
Published: 2026-01-12 doi: 10.16438/j.0513-4870.2025-0824
Outline
收藏切换

Epilepsy and its comorbidities affect the health of tens of millions of people, characterized by complex and poorly understood etiology. While anti-seizure medications (ASMs) remains the primary treatment approach, antiepileptic drugs face issues like drug resistance and severe side effects, highlighting an urgent need for novel drugs and therapeutic strategies. The gut microbiota plays a crucial role in the pathogenesis of central nervous system diseases. They can interact with the brain through the nervous, endocrine, immune and metabolic systems, thereby influencing the course of the disease. Some researches have indicated that gut microbiota-targeted interventions, such as the ketogenic diet (KD), fecal microbiota transplantation (FMT), and probiotics, demonstrate the significant potential in the treatment of epilepsy. However, there are still many unsolved mysteries regarding the role of gut bacteria in the onset and treatment of epilepsy. Investigating the regulatory role of the gut microbiota in epilepsy and its comorbidities holds great significance.

epilepsy  /  gut microbiota  /  pathogenesis  /  antiepileptic drug  /  new intervention strategy
冯茹, 左恒通, 鲁金月, 张波, 蒋建东, 王琰, 柳青. 基于肠道菌调控的癫痫治疗药物及干预新策略研究进展. 药学学报, 2026 , 61 (1) : 84 -93 . DOI: 10.16438/j.0513-4870.2025-0824
Ru FENG, Heng-tong ZUO, Jin-yue LU, Bo ZHANG, Jian-dong JIANG, Yan WANG, Qing LIU. Research progress on drug and new intervention strategies for epilepsy based on gut microbiota regulation[J]. Acta Pharmaceutica Sinica, 2026 , 61 (1) : 84 -93 . DOI: 10.16438/j.0513-4870.2025-0824
Year 2026 volume 61 Issue 1
232
104
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0824
  • Receive Date:2025-07-15
  • Online Date:2026-09-21
  • Published:2026-01-12
Article Data
Affiliations
History
  • Received:2025-07-15
  • Revised:2025-11-05
Affiliations
    1Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
    2Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100005, China
    3Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100005, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0824
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT